Tomer Mark, MD

Articles by Tomer Mark, MD

Tomer Mark, MD

Dr. Mark on Questions Regarding Sequencing in Multiple Myeloma

ByTomer Mark, MD

January 5th 2022

Tomer Mark, MD, discusses making sequencing decisions amid the array of available treatment options in multiple myeloma.

Tomer Mark, MD

Dr. Mark on Establishing MRD as a Surrogate Marker for Survival in Multiple Myeloma

ByTomer Mark, MD

December 16th 2021

Tomer Mark, MD, discusses establishing minimal residual disease (MRD) as a surrogate marker for survival in multiple myeloma.

Latest Updated Articles

Trending on OncLive

RELATIVITY-1093 Trial Aims to Advance Nivolumab Plus Relatlimab and Chemo in Nonsquamous NSCLC

Dostarlimab Monotherapy Elicits Durable cCRs in dMMR/MSI-H Locally Advanced Rectal Cancer

NEXERA-303 Trial Aims to Bring TGFβR2×PD-1 Bispecific Antibody INCA33890 Into First-Line MSS CRC

Krascendo 1 Survival Data Position Divarasib to Reset Second-Line Standards and Fuel First-Line Combinations in KRAS G12C–Mutated NSCLC

The OncFive: Top Oncology Articles for the Week of 10/25